SIS
PFE icon

Susquehanna International Securities’s Pfizer PFE Stock Holding History

Susquehanna International Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,600
Closed -$465K – 34
2022
Q3 		$465K Hold
10,600
– – 0.87% 16
2022
Q2 		$554K Hold
10,600
– – 0.4% 19
2022
Q1 		$550K Sell
10,600
-2,058
-16% -$107K 0.43% 12
2021
Q4 		$745K Buy
+12,658
New +$627K 0.45% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Securities's PFE Position: Q4 2022 in Review

Susquehanna International Securities sold out of Pfizer (PFE) in Q4 2022, closing a stake of 10,600 shares — an estimated $465K sold.

Susquehanna International Securities first reported a position in PFE in Q4 2021 and held it in 4 quarters. The position peaked at $745K in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Susquehanna International Securities reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Securities sold 10,600 Pfizer shares in Q4 2022, an estimated $465K.
  • Susquehanna International Securities first reported a position in Pfizer in Q4 2021 and held it in 4 quarters.
  • Susquehanna International Securities's Pfizer position peaked at $745K in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Susquehanna International Securities's 13F filing for Q4 2022, filed 14 Feb 2023.